Jabil Inc. · NYSE:JBL

Jabil — Investor Day (September 2016)

11 slides from Jabil's investor day presentation, Sep 27, 2016

  1. Slide 1: 2016 Jabil Analyst & Investor Meeting

    2016 JABIL ANALYST & INVESTOR MEETING 1 SEPTEMBER 27, 2016

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Forward looking statements: This presentation contains forward-looking statements, including those regarding our anticipated financial results for our full fiscal year 2016; and our estimated positioning for future financial performance in our fiscal years 2017 through 201

  3. Slide 3: Healthcare

    Healthcare Steve Borges, Executive Vice President & CEO, Healthcare 3

  4. Slide 4: Healthcare Markets & Strategy

    Healthcare Markets & Strategy Devices Diagnostics Pharma Delivery Consumer Health Strategy: We improve patient outcomes by helping our customers rapidly innovate and reliably deliver safe, effective, efficient and globally relevant connected healthcare solutions 4

  5. Slide 5: Industry Transformation Plays to Jabil Strengths

    Industry Transformation Plays to Jabil Strengths Leverage breadth of Outcomes and Value- capabilities in Based Care transformational solutions Adherence & outcomes Aging population and too driven by user experience few physicians design $100-300B avoidable Regulatory expertise costs from patient ens

  6. Slide 6: Capabilities

    Capabilities Accelerated innovation and global relevance Formative and User Experience Product Summative Studies Design Localization Miniaturization Rapid Prototyping 3D Printing Smart, advanced feature enablers Sensors and Printed Flexible Complex EMS Battery Materials Integration Connectivity Bios

  7. Slide 7: Unique Capabilities Solve Customers' Biggest Problems

    Unique Capabilities Solve Customers’ Biggest Problems Capabilities: Improved Outcomes:  Insight discovery through product  Drug safety solution  Improve patient lives  NPI for clinical trials  Predict and prevent hospitalizations  Sensors, biosensors  Connectivity technologies  Warn of inapp

  8. Slide 8: Providing Value

    Providing Value Therapy Areas Product Domains Cardiovascular Patient monitoring Diabetes In vitro diagnostics Respiratory Drug delivery systems Neuroscience Imaging Orthopaedics Infusion systems Hematology/Oncology Blood management Gastroenterology Catheters Hepatology Surgical instruments Wellness

  9. Slide 9: Organic Growth: Strong Loyalty of the Biggest Players

    Organic Growth: Strong Loyalty of the Biggest Players Roche Diagnostics  Strong relationships with loyalty scores at historic highs.  Top 20 represented more than 50% of all medical device M&A deal values. 9

  10. Slide 10: How We Win

    How We Win ORGANIC GROWTH CUSTOMER LOYALTY LEVERAGE JABIL STRENGTHS Patient Provider Payer END-TO-END SOLUTIONS Customer ACCELERATED INNOVATION ADVANCED MATERIAL INTEGRATION CAPABILITY EXPANSION 10

  11. Slide 11: Thank You

    THANK YOU 11

Jabil — Investor Day (September 2016) on 6ix